Showing results (101-110 of 239) with videos related to
Sort By:
Pageof 24
Breast (Edinburgh, Scotland)|December 10, 2019
Putting words into practiceDonatella Decise, Mihaela Palade Gheran, Eti Kimhi, et al.Breast Cancer Research and Treatment|September 30, 2018
Male breast cancer: a disease distinct from female breast cancerAyca Gucalp, Tiffany A Traina, Joel R Eisner, et al.The Breast Journal|July 8, 2025
Underserved Patient Populations With Metastatic Breast Cancer: A Review of Progress and Remaining ChallengesFatima Cardoso, Rachel Wuerstlein, Tomoyuki Aruga, et al.Clinical Breast Cancer|January 21, 2003
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot studyChantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practiceYan Ma, Laurence Lespagnard, Virginie Durbecq, et al.The Lancet. Oncology|March 11, 2015
Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014Sandra R Distelhorst, James F Cleary, Patricia A Ganz, et al.Breast (Edinburgh, Scotland)|November 26, 2025
Increasing awareness of and referral to support services in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 7)Belinda Kiely, Luzia Travado, Andrea L Smith, et al.Molecular Cancer Therapeutics|December 7, 2006
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic mannerFatima Cardoso, Virginie Durbecq, Jean-François Laes, et al.Breast (Edinburgh, Scotland)|March 9, 2025
Awareness of genomic testing among patients with breast cancer in EuropeAntonella Cardone, Dany Bell, Conchi Biurrun, et al.Breast (Edinburgh, Scotland)|April 23, 2013
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancerNancy U Lin, Christoph Thomssen, Fatima Cardoso, et al.Pageof 24